ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1233
0,00%
Bitcoin
69.982,81
-0,21%
Brent Oil
82,19
-0,31%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vertex Pharmaceuticals Inc (VRTX)

  7. Vertex Pharmaceuticals Inc (VRTX) Notícias

VRTX Vertex Pharmaceuticals Inc

442,00
-3,87 (-0,87%)
21 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Vertex Pharmaceuticals Inc VRTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-3,87 -0,87% 442,00 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
446,00 437,4601 446,39 442,00 445,87
mais cotações »

Notícias Recentes

Data Hora Fonte Título
15/05/202411:30BWJennifer Schneider Elected to Vertex Board of Directors
07/05/202408:46IHMARKETNEWSDisney Slashes Streaming Losses, UBS shoots up 9% as profit..
06/05/202417:01BWVertex Reports First Quarter 2024 Financial Results
06/05/202409:09IHMARKETNEWSIndex Futures Point to Strong Monday Opening, Building on..
26/04/202412:43BWVertex Announces European Commission Approval for KALYDECO®..
23/04/202401:45PRNUSVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING..
18/04/202409:00BWVertex Announces Advancements of Suzetrigine (VX-548) in..
11/04/202408:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
10/04/202417:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
09/04/202417:05BWVertex to Announce First Quarter 2024 Financial Results on..
01/04/202412:00PRNCAVertex Announces New Drug Submission for Exagamglogene..
01/04/202409:00BWVertex Advances Inaxaplin (VX-147) into Phase 3 Portion of..
21/03/202409:00BWVertex Announces FDA Clearance of Investigational New Drug..
23/02/202409:10BWVertex Receives CHMP Positive Opinion for KALYDECO® for the..
20/02/202418:05BWVertex to Participate in Upcoming Investor Conferences
13/02/202403:59BWEuropean Commission Approves First CRISPR/Cas9 Gene-Edited..
06/02/202408:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
05/02/202418:06BWVertex Reports Fourth Quarter and Full Year 2023 Financial..
05/02/202418:01BWVertex Announces Positive Results From Pivotal Trials of..
30/01/202408:28BWVertex Announces Positive Results From the VX-548 Phase 3..
17/01/202410:00BWVertex to Announce Fourth Quarter and Full Year 2023..
16/01/202417:07DJNVertex Pharmaceuticals Says FDA Approved Casgevy for TDT..
16/01/202416:24BWVertex Announces US FDA Approval of CASGEVY™ (exagamglogene..
09/01/202414:42BWVertex Announces Approval of First CRISPR/Cas9 Gene-Edited..
07/01/202417:00BWVertex Provides Pipeline and Business Updates in Advance of..
18/12/202318:05BWVertex to Present at the 42nd Annual J.P. Morgan Healthcare..
15/12/202310:12BWVertex Receives CHMP Positive Opinion for the First..
14/12/202310:30APSCompany Intersects Salt
13/12/202314:48DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202312:49DJNVertex Pharmaceuticals Up Over 8%, on Track for Record High..
13/12/202311:49DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202308:30BWVertex Announces Positive Results From Phase 2 Study of..
11/12/202321:30BWPositive Results from Pivotal Trials of CASGEVY™..
08/12/202318:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
08/12/202314:52BWVertex and CRISPR Therapeutics Announce US FDA Approval of..
08/12/202313:46DJNCRISPR, Vertex Get FDA OK of Casgevy Gene Therapy in..
05/12/202318:01BWVertex Appoints Nancy Thornberry to its Board of Directors
29/11/202316:55DJNVertex Pharmaceuticals' Kalydeco Gets Expanded Use..
29/11/202316:00PRNCASanté Canada autorise la mise sur le marché de KALYDECO(MD)..
29/11/202315:59PRNCAHealth Canada Grants Market Authorization for KALYDECO®..
24/11/202312:06DJNVertex Pharmaceuticals Gets Regulatory OK to Extend Use to..
24/11/202311:13BWVertex Announces European Medicines Agency Validation for..
23/11/202311:54DJNVertex Pharmaceuticals Cystic Fibrosis Treatment Approved..
23/11/202311:05BWEuropean Commission Approves KAFTRIO® in Combination With..
16/11/202303:45BW Vertex and CRISPR Therapeutics Announce Authorization of..
15/11/202316:32DJNVertex Pharmaceuticals Worst Performer in the S&P 500 and..
07/11/202309:10IHMARKETNEWSTuesday’s Wall Street Highlights: WeWork, UBS, Sanofi,..
06/11/202318:46DJNVertex Pharmaceuticals 3Q Profit Rises on Continued Sales..
06/11/202318:01BWVertex Reports Third Quarter 2023 Financial Results
02/11/202310:02BWVertex to Present New Data on Exagamglogene Autotemcel..

Seu Histórico Recente

NASDAQ
VRTX
Vertex Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados